BSTG - Biostage, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 519.37M
Enterprise Value 318.17M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)11.27
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-2.12

Trading Information

Stock Price History

Beta (3Y Monthly) 2.70
52-Week Change 3-12.70%
S&P500 52-Week Change 33.55%
52 Week High 33.4600
52 Week Low 30.7500
50-Day Moving Average 32.4118
200-Day Moving Average 32.3952

Share Statistics

Avg Vol (3 month) 32.02k
Avg Vol (10 day) 31.75k
Shares Outstanding 57.02M
Float 2.57M
% Held by Insiders 169.82%
% Held by Institutions 10.24%
Shares Short (Sep 29, 2017) 4121.66k
Short Ratio (Sep 29, 2017) 43.35
Short % of Float (Sep 29, 2017) 47.13%
Short % of Shares Outstanding (Sep 29, 2017) 46.25%
Shares Short (prior month Aug 31, 2017) 4201.81k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 220/1
Last Split Date 3Dec 22, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-117.34%
Return on Equity (ttm)-232.49%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -8.58M
Net Income Avi to Common (ttm)-8.28M
Diluted EPS (ttm)-1.3810
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.25M
Total Cash Per Share (mrq)0.18
Total Debt (mrq)119k
Total Debt/Equity (mrq)6.93
Current Ratio (mrq)2.28
Book Value Per Share (mrq)0.25

Cash Flow Statement

Operating Cash Flow (ttm)-7.66M
Levered Free Cash Flow (ttm)-5.02M